SEC Form 4 · accession 0001127602-18-031597
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nilda Mesa
Director
Period of report
Oct 31, 2018
Accepted (ET)
Nov 1, 2018 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $110.86 | Oct 31, 2018 | A | 6,560 | A | Oct 31, 2019 | Oct 31, 2028 | Common Stock | 6,560 | 6,560 | D |
| Restricted Stock UnitsF2,F3 | $0.00 | Oct 31, 2018 | A | 2,660 | A | — | — | Common Stock | 2,660 | 2,660 | D |
Explanation of responses
- F1Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.
- F2Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
- F3The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares.